Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT demonstrates a positive outlook due to improvements in occupancy and rent coverage, suggesting a stronger financial performance and stability within its nursing facilities, assisted living centers, and mental health facilities. The expected recovery in the seniors housing managed portfolio is anticipated to enhance the company's leverage profile, positioning Sabra to capitalize on accretive growth opportunities. Moreover, the increase in the 2025 funds from operations (FFO) estimate to $1.54 per share, driven by favorable gains and increased investment volume, indicates a solid growth trajectory for the company.

Bears say

Sabra Health Care REIT faces challenges stemming from unpredictable individual operator performance, particularly as some operators struggle to meet rent obligations amid an inflationary cost environment. The company's financial positioning indicates it is not as low-levered as several peers, while its stock trades near the high end of its historical valuation range, suggesting limited potential for immediate earnings growth from acquisitions. Additionally, the current cost of equity appears to restrict the company’s capacity for generating significant earnings accretion in a competitive healthcare REIT sector.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.